{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:50:43Z","timestamp":1761648643378,"version":"3.44.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bulcan.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T22:31:58Z","timestamp":1560378718000},"page":"784-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prise en charge m\u00e9dicamenteuse des douleurs neuropathiques p\u00e9riph\u00e9riques li\u00e9es au cancer\u00a0: une revue syst\u00e9matique de la litt\u00e9rature"],"prefix":"10.1016","volume":"106","author":[{"given":"Jacques","family":"Medioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gis\u00e8le","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Lansaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Lanteri-Minet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Legras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malou","family":"Navez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Prudhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Serrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Viel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980\u00a0et 2012. Partie 1\u2013Tumeurs solides [Internet]","author":"Binder-Foucard","key":"10.1016\/j.bulcan.2019.04.009_bib0325"},{"issue":"10125","key":"10.1016\/j.bulcan.2019.04.009_bib0330","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,513,025\u00a0patients diagnosed with one of 18\u00a0cancers from 322\u00a0population-based registries in 71\u00a0countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.009_bib0335","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3122\/jabfm.2007.05.060225","article-title":"Symptom burden among cancer survivors: impact of age and comorbidity","volume":"20","author":"Mao","year":"2007","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"10.1016\/j.bulcan.2019.04.009_bib0340","doi-asserted-by":"crossref","first-page":"488","DOI":"10.6004\/jnccn.2014.0054","article-title":"Survivorship: pain version 1.2014","volume":"12","author":"Denlinger","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"year":"2018","series-title":"La vie cinq ans apr\u00e8s un diagnostic de cancer [Internet]","author":"INCa","key":"10.1016\/j.bulcan.2019.04.009_bib0345"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/papr.12036","article-title":"Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in national clinical practice guidelines from European countries","volume":"14","author":"Piano","year":"2014","journal-title":"Pain Pract"},{"year":"2018","series-title":"IASP Terminology. [Internet]","key":"10.1016\/j.bulcan.2019.04.009_bib0355"},{"issue":"6","key":"10.1016\/j.bulcan.2019.04.009_bib0360","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/j.pain.0000000000000895","article-title":"Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer","volume":"158","author":"Bouhassira","year":"2017","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0365","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11764-017-0650-z","article-title":"Chronic neuropathic pain negatively associated with employment retention of cancer survivors: evidence from a national French survey","volume":"12","author":"Alleaume","year":"2018","journal-title":"J Cancer Surviv"},{"issue":"2","key":"10.1016\/j.bulcan.2019.04.009_bib0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/SPC.0000000000000261","article-title":"Pain prevalence in cancer patients: status quo or opportunities for improvement?","volume":"11","author":"Haumann","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01050259","article-title":"Long-term effects of vincristine on the peripheral nervous system","volume":"15","author":"Postma","year":"1993","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.bulcan.2019.04.009_bib0380","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/1097-0142(19900915)66:6<1117::AID-CNCR2820660607>3.0.CO;2-O","article-title":"Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps","volume":"66","author":"Siegal","year":"1990","journal-title":"Cancer"},{"issue":"30","key":"10.1016\/j.bulcan.2019.04.009_bib0385","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","article-title":"Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (Alliance)","volume":"33","author":"Pachman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0390","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.47.1.115","article-title":"Motor neuropathy due to docetaxel and paclitaxel","volume":"47","author":"Freilich","year":"1996","journal-title":"Neurology"},{"issue":"27","key":"10.1016\/j.bulcan.2019.04.009_bib0395","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2006.05.6689","article-title":"Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring","volume":"24","author":"Mileshkin","year":"2006","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.bulcan.2019.04.009_bib0400","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2019.04.009_bib0405","first-page":"756","article-title":"Diagnosis and management of brachial plexus lesions in cancer patients","volume":"9","author":"Kori","year":"1995","journal-title":"Oncology (Williston Park)"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.009_bib0410","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0360-3016(01)02743-2","article-title":"Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients","volume":"52","author":"Johansson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.revinf.2015.01.005","article-title":"Analgesic treatment of cancer pain","volume":"210","author":"Ghimouz","year":"2015","journal-title":"Rev Infirm"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0420","first-page":"3","article-title":"Les douleurs neuropathiques chroniques\u00a0: diagnostic, \u00e9valuation et traitement en m\u00e9decine ambulatoire. Recommandations pour la pratique clinique de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019\u00e9tude et de traitement de la douleur","volume":"11","author":"Martinez","year":"2010","journal-title":"Douleurs"},{"year":"2015","series-title":"OM\u00e9DIT\u2013Commission Douleur\u00a0: Fiche de bon usage. Actualisation","key":"10.1016\/j.bulcan.2019.04.009_bib0425"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0430","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0435","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/DDDT.S142630","article-title":"Localized neuropathic pain: an expert consensus on local treatments","volume":"11","author":"Pickering","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.bulcan.2019.04.009_bib0440","doi-asserted-by":"crossref","first-page":"e1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010\u00a0revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0445","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.douler.2017.07.007","article-title":"Consensus multidisciplinaire d\u2019experts en douleur et g\u00e9riatrie\u00a0: utilisation des antalgiques dans la prise en charge de la douleur de la personne \u00e2g\u00e9e (hors anesth\u00e9sie)","volume":"18","author":"Capriz","year":"2017","journal-title":"Douleurs \u00c9valuation\u2013Diagnostic\u2013Traitement"},{"issue":"8","key":"10.1016\/j.bulcan.2019.04.009_bib0450","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40266-016-0389-7","article-title":"An algorithm for neuropathic pain management in older persons","volume":"33","author":"Pickering","year":"2016","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.bulcan.2019.04.009_bib0455","doi-asserted-by":"crossref","first-page":"1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"157","key":"10.1016\/j.bulcan.2019.04.009_bib0460","first-page":"39","article-title":"Traduction fran\u00e7aise des lignes directrices PRISMA pour l\u2019\u00e9criture et la lecture des revues syst\u00e9matiques et des m\u00e9ta-analyses","volume":"15","author":"Gedda","year":"2015","journal-title":"Kinesither Rev"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0465","series-title":"Chemotherapy-induced painful neuropathy (CIN): treatment with the capsaicin 8\u00a0% patch","first-page":"466","author":"Bhaskar","year":"2012"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1049909112443586","article-title":"Management of severe neuropathic cancer pain: an illustrative case and review","volume":"30","author":"Connolly","year":"2013","journal-title":"Am J Hosp Palliat Care"},{"issue":"9","key":"10.1016\/j.bulcan.2019.04.009_bib0475","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1089\/jpm.2012.0594","article-title":"Rotating to oral methadone in advanced cancer patients: a case series","volume":"16","author":"Kilonzo","year":"2013","journal-title":"J Palliat Med"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.009_bib0480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1533-2500.2012.00569.x","article-title":"Subcutaneous botulinum toxin for chronic post-thoracotomy pain","volume":"13","author":"Fabregat","year":"2013","journal-title":"Pain Pract"},{"issue":"4","key":"10.1016\/j.bulcan.2019.04.009_bib0485","doi-asserted-by":"crossref","first-page":"e59981","DOI":"10.1371\/journal.pone.0059981","article-title":"Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients","volume":"8","author":"Garassino","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.bulcan.2019.04.009_bib0490","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy (CIPN): a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.009_bib0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/15360288.2014.938881","article-title":"Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain","volume":"28","author":"Amin","year":"2014","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.009_bib0500","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1049909112454325","article-title":"Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?","volume":"30","author":"Okamoto","year":"2013","journal-title":"Am J Hosp Palliat Care"},{"issue":"9","key":"10.1016\/j.bulcan.2019.04.009_bib0505","first-page":"2769","article-title":"Cancer treatment-related neuropathic pain: proof of concept study with menthol\u2014A TRPM8\u00a0agonist","volume":"23","author":"Fallon","year":"2015","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.009_bib0510","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0269216314556923","article-title":"A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit","volume":"29","author":"Hilliard","year":"2015","journal-title":"Palliat Med"},{"issue":"15\u00a0Suppl.","key":"10.1016\/j.bulcan.2019.04.009_bib0515","doi-asserted-by":"crossref","first-page":"e14031","DOI":"10.1200\/JCO.2016.34.15_suppl.e14031","article-title":"Improvement of chemotherapy induced neuropathy (CIN) in cancer patients using capsaicin 8\u00a0% patch","volume":"34","author":"Le Marec","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0520","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8010022","article-title":"Incobotulinum toxin-A improves post-surgical and post-radiation pain in cancer patients","volume":"8","author":"Rostami","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.bulcan.2019.04.009_bib0525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/joor.12347","article-title":"Bilateral glossopharyngeal neuropathy following chemo and radiation therapy for a primitive neuroectodermal tumour","volume":"43","author":"Heir","year":"2016","journal-title":"J Oral Rehabil"},{"issue":"2","key":"10.1016\/j.bulcan.2019.04.009_bib0530","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/ajco.12311","article-title":"Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy","volume":"13","author":"Dou","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2019.04.009_bib0535","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12032-017-1015-1","article-title":"High-dose 8\u00a0% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience","volume":"34","author":"Filipczak-Bryniarska","year":"2017","journal-title":"Med Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2019.04.009_bib0540","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12094-012-0831-1","article-title":"Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice","volume":"14","author":"Virizuela","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2019.04.009_bib0545","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/jjco\/hyt099","article-title":"Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations","volume":"43","author":"Yamaguchi","year":"2013","journal-title":"Jpn J Clin Oncol"},{"issue":"18","key":"10.1016\/j.bulcan.2019.04.009_bib0550","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4\u00a0Suppl.\u00a01","key":"10.1016\/j.bulcan.2019.04.009_bib0555","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00325481.2013.1110567111","article-title":"Topical therapies in the management of chronic pain","volume":"125","author":"Stanos","year":"2013","journal-title":"Postgrad Med"},{"issue":"12","key":"10.1016\/j.bulcan.2019.04.009_bib0560","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11916-014-0463-y","article-title":"Drug combinations in the treatment of neuropathic pain","volume":"18","author":"Eisenberg","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aet208","article-title":"Neuropathic pain in cancer","volume":"111","author":"Fallon","year":"2013","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.009_bib0570","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/0284186X.2014.996662","article-title":"Pain management in cancer survivorship","volume":"54","author":"Kurita","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656566.2015.980723","article-title":"Pain management of the cancer patient","volume":"16","author":"Schug","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"10.1016\/j.bulcan.2019.04.009_bib0580","doi-asserted-by":"crossref","first-page":"380","DOI":"10.12968\/ijpn.2015.21.8.380","article-title":"Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management","volume":"21","author":"Taverner","year":"2015","journal-title":"Int J Palliat Nurs"},{"issue":"2","key":"10.1016\/j.bulcan.2019.04.009_bib0585","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bulcan.2019.04.009_bib0590","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2\u00a0antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.009_bib0595","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0150-9861(04)96992-1","article-title":"[MRI of the brachial plexus]","volume":"31","author":"Petit Lacour","year":"2004","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0600","first-page":"2261","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0605","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpainsymman.2016.12.342","article-title":"Chemotherapy-induced neuropathy in cancer survivors","volume":"54","author":"Miaskowski","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2019.04.009_bib0610","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2017.00086","article-title":"Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review","volume":"8","author":"Kerckhove","year":"2017","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.bulcan.2019.04.009_bib0615","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliat Med"},{"issue":"11","key":"10.1016\/j.bulcan.2019.04.009_bib0620","first-page":"1020","article-title":"New practical approaches to chemotherapy-induced neuropathic pain: prevention, assessment, and treatment","volume":"30","author":"Majithia","year":"2016","journal-title":"Oncology (Williston Park)"},{"issue":"4","key":"10.1016\/j.bulcan.2019.04.009_bib0625","doi-asserted-by":"crossref","first-page":"e0152741","DOI":"10.1371\/journal.pone.0152741","article-title":"Memantine before mastectomy prevents post-surgery pain: a randomized, blinded clinical trial in surgical patients","volume":"11","author":"Morel","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bulcan.2019.04.009_bib0630","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1172\/JCI68730","article-title":"Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir","volume":"124","author":"Coriat","year":"2014","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.bulcan.2019.04.009_bib0635","first-page":"3407","article-title":"A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I","volume":"25","author":"Pachman","year":"2017","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2019.04.009_bib0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/0284186X.2017.1398836","article-title":"Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx\u00ae): a placebo-controlled randomised phase II study (PLIANT)","volume":"57","author":"Glimelius","year":"2018","journal-title":"Acta Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119302206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119302206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:31:25Z","timestamp":1757791885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455119302206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0007455119302206"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.04.009","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge m\u00e9dicamenteuse des douleurs neuropathiques p\u00e9riph\u00e9riques li\u00e9es au cancer\u00a0: une revue syst\u00e9matique de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}